Rhus toxicodendron comp. Soluzione iniettabile (s. c.)

Country: Switzerland

Language: Italian

Source: Swissmedic (Swiss Agency for Therapeutic Products)

Active ingredient:

aconitum napellus e tubere rec. ferm 33c D5 (HAB 33c), gelsemium sempervirens e rhizoma siccata ferm 35b D3 (HAB 35b), granit D9 (HAB 6/8b), leontopodium alpinum e planta tota siccata ferm 36 D3 (HAB 36), mandragora officinarum e radice rec. ferm 34d D5 (HAB 34d), toxicodendron quercifolium e foliis rec. ferm 33d D5 (HAB 33d)

Available from:

WALA Schweiz AG

INN (International Name):

aconitum napellus e tubere rec. ferm 33c D5 (HAB 33c), gelsemium sempervirens e rhizoma siccata ferm 35b D3 (HAB 35b), granit D9 (HAB 6/8b), leontopodium alpinum e planta tota siccata ferm 36 D3 (HAB 36), mandragora officinarum e radice rec. ferm 34d D5 (HAB 34d), toxicodendron quercifolium e foliis rec. ferm 33d D5 (HAB 33d)

Pharmaceutical form:

Soluzione iniettabile (s. c.)

Composition:

aconitum napellus e tubere rec. ferm 33c D5 (HAB 33c) 100 mg, gelsemium sempervirens e rhizoma siccata ferm 35b D3 (HAB 35b) 100 mg, granit D9 (HAB 6/8b) 100 mg, leontopodium alpinum e planta tota siccata ferm 36 D3 (HAB 36) 100 mg, mandragora officinarum e radice rec. ferm 34d D5 (HAB 34d) 100 mg, toxicodendron quercifolium e foliis rec. ferm 33d D5 (HAB 33d) 100 mg, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile, pro vitro 1 ml corresp. natrium 3.46 mg.

Class:

B

Therapeutic group:

Antroposofici

Therapeutic area:

Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)

Authorization status:

zugelassen

Authorization date:

2014-01-29